Literature DB >> 21646361

Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.

Seiji Adachi1, Ichiro Yasuda, Masanori Nakashima, Takahiro Yamauchi, Junji Kawaguchi, Masahito Shimizu, Masahiko Itani, Momoko Nakamura, Yumi Nishii, Takashi Yoshioka, Yoshinobu Hirose, Yukio Okano, Hisataka Moriwaki, Osamu Kozawa.   

Abstract

Receptor down-regulation is the most prominent regulatory system of EGF receptor (EGFR) signal attenuation and a critical target for therapy against colon cancer, which is highly dependent on the function of the EGFR. In this study, we investigated the effect of ultraviolet-C (UV-C) on down-regulation of EGFR in human colon cancer cells (SW480, HT29, and DLD-1). UV-C caused inhibition of cell survival and proliferation, concurrently inducing the decrease in cell surface EGFR and subsequently its degradation. UV-C, as well as EGFR kinase inhibitors, decreased the expression level of cyclin D1 and the phosphorylated level of retinoblastoma, indicating that EGFR down-regulation is correlated to cell cycle arrest. Although UV-C caused a marked phosphorylation of EGFR at Ser-1046/1047, UV-C also induced activation of p38 MAPK, a stress-inducible kinase believed to negatively regulate tumorigenesis, and the inhibition of p38 MAPK canceled EGFR phosphorylation at Ser-1046/1047, as well as subsequent internalization and degradation, suggesting that p38 MAPK mediates EGFR down-regulation by UV-C. In addition, phosphorylation of p38 MAPK induced by UV-C was mediated through transforming growth factor-β-activated kinase-1. Moreover, pretreatment of the cells with UV-C suppressed EGF-induced phosphorylation of EGFR at tyrosine residues in addition to cell survival signal, Akt. Together, these results suggest that UV-C irradiation induces the removal of EGFRs from the cell surface that can protect colon cancer cells from oncogenic stimulation of EGF, resulting in cell cycle arrest. Hence, UV-C might be applied for clinical strategy against human colon cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646361      PMCID: PMC3138318          DOI: 10.1074/jbc.M111.240630

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Signaling on the endocytic pathway.

Authors:  P S McPherson; B K Kay; N K Hussain
Journal:  Traffic       Date:  2001-06       Impact factor: 6.215

2.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.

Authors:  G Levkowitz; H Waterman; S A Ettenberg; M Katz; A Y Tsygankov; I Alroy; S Lavi; K Iwai; Y Reiss; A Ciechanover; S Lipkowitz; Y Yarden
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

3.  HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells.

Authors:  Seiji Adachi; Ichiro Yasuda; Masanori Nakashima; Takahiro Yamauchi; Junichi Yamauchi; Hideo Natsume; Hisataka Moriwaki; Osamu Kozawa
Journal:  Oncol Rep       Date:  2010-06       Impact factor: 3.906

4.  Rho-kinase regulates negatively the epidermal growth factor-stimulated colon cancer cell proliferation.

Authors:  Masanori Nakashima; Seiji Adachi; Ichiro Yasuda; Takahiro Yamauchi; Osamu Kozawa; Hisataka Moriwaki
Journal:  Int J Oncol       Date:  2010-03       Impact factor: 5.650

5.  (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells.

Authors:  Seiji Adachi; Tomokazu Nagao; Satoshi To; Andrew K Joe; Masahito Shimizu; Rie Matsushima-Nishiwaki; Osamu Kozawa; Hisataka Moriwaki; Frederick R Maxfield; I Bernard Weinstein
Journal:  Carcinogenesis       Date:  2008-06-26       Impact factor: 4.944

6.  (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.

Authors:  Seiji Adachi; Masahito Shimizu; Yohei Shirakami; Junichi Yamauchi; Hideo Natsume; Rie Matsushima-Nishiwaki; Satoshi To; I Bernard Weinstein; Hisataka Moriwaki; Osamu Kozawa
Journal:  Carcinogenesis       Date:  2009-07-03       Impact factor: 4.944

7.  p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047.

Authors:  Seiji Adachi; Hideo Natsume; Junichi Yamauchi; Rie Matsushima-Nishiwaki; Andrew K Joe; Hisataka Moriwaki; Osamu Kozawa
Journal:  Cancer Lett       Date:  2009-01-12       Impact factor: 8.679

Review 8.  Mechanisms for oncogenic activation of the epidermal growth factor receptor.

Authors:  Roza Zandi; Alice Bjerregaard Larsen; Peter Andersen; Marie-Thérése Stockhausen; Hans Skovgaard Poulsen
Journal:  Cell Signal       Date:  2007-07-04       Impact factor: 4.315

9.  Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes.

Authors:  Deepa R Hammaker; David L Boyle; Tomoyuki Inoue; Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality.

Authors:  G Milano; J-P Spano; B Leyland-Jones
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

View more
  5 in total

1.  Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells.

Authors:  Junji Kawaguchi; Seiji Adachi; Ichiro Yasuda; Takahiro Yamauchi; Masanori Nakashima; Tomohiko Ohno; Masahito Shimizu; Takashi Yoshioka; Masahiko Itani; Osamu Kozawa; Hisataka Moriwaki
Journal:  Mol Cancer       Date:  2012-07-12       Impact factor: 27.401

2.  UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells.

Authors:  Junji Kawaguchi; Seiji Adachi; Ichiro Yasuda; Takahiro Yamauchi; Takashi Yoshioka; Masahiko Itani; Osamu Kozawa; Hisataka Moriwaki
Journal:  Oncol Rep       Date:  2011-12-23       Impact factor: 3.906

3.  Modulating the structure of EGFR with UV light: new possibilities in cancer therapy.

Authors:  Manuel Correia; Viruthachalam Thiagarajan; Isabel Coutinho; Gnana Prakash Gajula; Steffen B Petersen; Maria Teresa Neves-Petersen
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

4.  Combined Treatment with Low Cytotoxic Ethyl Acetate Nepenthes Extract and Ultraviolet-C Improves Antiproliferation to Oral Cancer Cells via Oxidative Stress.

Authors:  Sheng-Yao Peng; Li-Ching Lin; Zhe-Wei Yang; Fang-Rong Chang; Yuan-Bin Cheng; Jen-Yang Tang; Hsueh-Wei Chang
Journal:  Antioxidants (Basel)       Date:  2020-09-16

5.  Oxidative Stress-Dependent Synergistic Antiproliferation, Apoptosis, and DNA Damage of Ultraviolet-C and Coral-Derived Sinularin Combined Treatment for Oral Cancer Cells.

Authors:  Sheng-Yao Peng; Jen-Yang Tang; Ruei-Nian Li; Hurng-Wern Huang; Chang-Yi Wu; Chien-Chih Chiu; Fang-Rong Chang; Hong-Wei Zhang; Yun-Jou Lee; Jyh-Horng Sheu; Hsueh-Wei Chang
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.